Page last updated: 2024-10-30

metformin and Leishmaniasis, American

metformin has been researched along with Leishmaniasis, American in 1 studies

Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.

Research Excerpts

ExcerptRelevanceReference
"Metformin (MET) is a hypoglycemic drug used for the treatment of diabetes, despite interference in host immunity against microorganisms."1.56Metformin promotes susceptibility to experimental Leishmania braziliensis infection. ( Arruda, S; Bonyek-Silva, I; Carvalho Filho, EM; Ferreira, LM; Lima, FR; Malta, TA; Santos, RL; Tavares, NM, 2020)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Lima, FR1
Ferreira, LM1
Malta, TA1
Bonyek-Silva, I1
Santos, RL1
Tavares, NM1
Carvalho Filho, EM1
Arruda, S1

Other Studies

1 other study available for metformin and Leishmaniasis, American

ArticleYear
Metformin promotes susceptibility to experimental Leishmania braziliensis infection.
    Memorias do Instituto Oswaldo Cruz, 2020, Volume: 115

    Topics: Animals; Brazil; Leishmania; Leishmania braziliensis; Leishmaniasis, Cutaneous; Metformin; Mice; Mic

2020